Abstract. Macrophage migration inhibitory factor (MIF)plays an important role in inflammatory diseases. It has been reported that anti-MIF treatment and mif-gene disruption ameliorate joint inflammation in a mouse model of arthritis induced by anti-type II collagen monoclonal antibodies and lipopolysaccharide (anti-IIC mAb/LPS). In the present study, using the anti-IIC mAb/LPS system, we have analyzed arthritis in MIF-transgenic (MIF Tg ) and wild-type C57BL/6 (WT) mice. We found that MIF Tg mice developed more severe arthritis than WT mice. The histopathological scores were significantly higher in MIF Tg mice and significantly increased numbers of CD69 + T cells were detected in the spleens of these arthritic MIF Tg mice, compared with WT mice. Natural killer T (NKT) cells from MIF Tg mice, compared with WT mice, produced reduced amounts of IL-4 upon stimulation with ·-galactosylceramide (·-GalCer). Further, repeated administration of ·-GalCer to MIF Tg mice resulted in a profound reduction of both clinical and histopathological scores of arthritis, with a significant decrease in IL-6. The present findings demonstrate that overexpression of MIF exacerbates inflammation in this arthritis model and that NKT cells play an ameliorating role upon stimulation with ·-GalCer in the inflammatory process in MIF Tg mice.